• THAT   AND
  • THAT   AND


Homo sapiens tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1, mRNA.


RefSeq Accession Definition Sequence Price Select
NM_001243 Homo sapiens tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1, mRNA. Full Lenth $1290.10
ORF Sequence $518.52


RefSeq Version NM_001243.3, 68348710
Length 3686 bp
Structure linear
Update Date 24-APR-2011
Organism Homo sapiens (human)
Definition Homo sapiens tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1, mRNA.
Product tumor necrosis factor receptor superfamily member 8 isoform 1 precursor
Comment

Summary: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq].


Transcript Variant: This variant (1) represents the longer transcript and encodes the longer isoform (1).

RefSeq NP_001234.2
CDS 223..2010
Exon (1)1..285
Exon (2)1..285
Exon (3)286..373
Exon (4)374..490
Exon (5)491..643
Exon (6)644..734
Exon (7)735..898
Exon (8)899..1015
Exon (9)1016..1168
Exon (10)1169..1262
Exon (11)1263..1375
Exon (12)1376..1477
Exon (13)1478..1531
Exon (14)1532..1557
Exon (15)1558..1765
Exon (16)1766..3686
Translation MRVLLAALGLLFLGALRAFPQDRPFEDTCHGNPSHYYDKAVRRCCYRCPMGLFPTQQCPQ RPTDCRKQCEPDYYLDEADRCTACVTCSRDDLVEKTPCAWNSSRVCECRPGMFCSTSAVN SCARCFFHSVCPAGMIVKFPGTAQKNTVCEPASPGVSPACASPENCKEPSSGTIPQAKPT PVSPATSSASTMPVRGGTRLAQEAASKLTRAPDSPSSVGRPSSDPGLSPTQPCPEGSGDC RKQCEPDYYLDEAGRCTACVSCSRDDLVEKTPCAWNSSRTCECRPGMICATSATNSRARC VPYPICAAETVTKPQDMAEKDTTFEAPPLGTQPDCNPTPENGEAPASTSPTQSLLVDSQA SKTLPIPTSAPVALSSTGKPVLDAGPVLFWVILVLVVVVGSSAFLLCHRRACRKRIRQKL HLCYPVQTSQPKLELVDSRPRRSSTQLRSGASVTEPVAEERGLMSQPLMETCHSVGAAYL ESLPLQDASPAGGPSSPRDLPEPRVSTEHTNNKIEKIYIMKADTVIVGTVKAELPEGRGL AGPAEPELEEELEADHTPHYPEQETEPPLGSCSDVMLSVEEEGKEDPLPTAASGK
Order your protein of interest with our Guaranteed or It's Free Service now! For details, please click here.
Position Chain Variation Link
66+g, tdbSNP:11569785
88+c, gdbSNP:34926532
492+c, tdbSNP:2230622
506+a, gdbSNP:72861979
549+a, gdbSNP:11569851
876+a, gdbSNP:61760049
993+a, gdbSNP:2230623
1005+c, tdbSNP:61749274
1035+a, gdbSNP:114975232
1040+g, tdbSNP:2230624
complement(1111)-g, adbSNP:1763642
complement(1162)-g, adbSNP:2275170
1200+a, gdbSNP:11569904
1278+a, gdbSNP:111344887
1426+a, gdbSNP:2230625
1538+g, tdbSNP:59566987
1548+a, gdbSNP:11569933
1569+c, tdbSNP:476488
1619+a, gdbSNP:35511003
1733+a, gdbSNP:2230627
1767+g, tdbSNP:77721961
1788+c, tdbSNP:111313258
1920+a, cdbSNP:74990522
2314+a, gdbSNP:11569949
2376+c, tdbSNP:11121880
2580+a, gdbSNP:11569950
2605+a, cdbSNP:75100997
2617+a, gdbSNP:11569951
2668+c, gdbSNP:111829026
2707..2708+, tgggcccagggcctdbSNP:11569952
2751+c, tdbSNP:115051836
2991+a, cdbSNP:79428703
3022..3023+c, gdbSNP:520311
3023+c, gdbSNP:41480747
3024..3025+, gcdbSNP:11569954
3077+a, cdbSNP:79902471
3148+a, gdbSNP:74053024
3184+c, tdbSNP:7525045
3197+c, gdbSNP:11569955
3294+c, tdbSNP:11569956
3296+c, gdbSNP:11569957
3300+a, c, g, tdbSNP:544065
3509+a, cdbSNP:118071918
3602+a, cdbSNP:11569958
Gene SymbolTNFRSF8
Gene SynonymCD30; D1S166E; Ki-1
Chromosome1
Locus Map1p36
All Transcripts NM_001243 , NM_152942
Title Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases .
Author Haque,T., Chaggar,T., Schafers,J., Atkinson,C., McAulay,K.A. and Crawford,D.H.
Journal J. Med. Virol. 83 (2), 311-316 (2011)
Title Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption .
Author Sawada,Y., Yoshiki,R., Kawakami,C., Fukamachi,S., Sugita,K., Nakamura,M. and Tokura,Y.
Journal Acta Derm. Venereol. 90 (5), 521-522 (2010)
Title CD30 discriminates heat shock protein 60-induced FOXP3+ CD4+ T cells with a regulatory phenotype .
Author de Kleer,I., Vercoulen,Y., Klein,M., Meerding,J., Albani,S., van der Zee,R., Sawitzki,B., Hamann,A., Kuis,W. and Prakken,B.
Journal J. Immunol. 185 (4), 2071-2079 (2010)
Title A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation .
Author Hubel,K., Cremer,B., Heuser,E., von Strandmann,E.P., Hallek,M. and Hansen,H.P.
Journal Transpl. Immunol. 23 (4), 215-219 (2010)
Title Increased expression of ganglioside GM1 in peripheral CD4+ T cells correlates soluble form of CD30 in Systemic Lupus Erythematosus patients .
Author Dong,L., Hu,S., Chen,F., Lei,X., Tu,W., Yu,Y., Yang,L., Sun,W., Yamaguchi,T., Masaki,Y. and Umehara,H.
Journal J. Biomed. Biotechnol. 2010, 569053 (2010)
Title Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources .
Author Jung,W., Krueger,S., Renner,C., Gause,A., Sahin,U., Trumper,L. and Pfreundschuh,M.
Journal Mol. Immunol. 31 (17), 1329-1334 (1994)
Title Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3 .
Author Shiota,M., Fujimoto,J., Semba,T., Satoh,H., Yamamoto,T. and Mori,S.
Journal Oncogene 9 (6), 1567-1574 (1994)
Title Assignment of the human CD30 (Ki-1) gene to 1p36 .
Author Fonatsch,C., Latza,U., Durkop,H., Rieder,H. and Stein,H.
Journal Genomics 14 (3), 825-826 (1992)
Title Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease .
Author Durkop,H., Latza,U., Hummel,M., Eitelbach,F., Seed,B. and Stein,H.
Journal Cell 68 (3), 421-427 (1992)
Title Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay .
Author Josimovic-Alasevic,O., Durkop,H., Schwarting,R., Backe,E., Stein,H. and Diamantstein,T.
Journal Eur. J. Immunol. 19 (1), 157-162 (1989)

Our customer service representatives are available 24 hours a day, Monday through Friday; please contact us anytime for assistance.

Secured Online Quotation
Email: gene@genscript.com
Phone: 1-877-436-7274 (Toll-Free) 1-732-885-9188
Fax: 1-732-210-0262 1-732-885-5878